These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24320552)

  • 1. Mathematical modeling of the in vitro hepatic disposition of mycophenolic acid and its glucuronide in sandwich-cultured human hepatocytes.
    Matsunaga N; Wada S; Nakanishi T; Ikenaga M; Ogawa M; Tamai I
    Mol Pharm; 2014 Feb; 11(2):568-79. PubMed ID: 24320552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling approach for multiple transporters-mediated drug-drug interactions in sandwich-cultured human hepatocytes: effect of cyclosporin A on hepatic disposition of mycophenolic acid phenyl-glucuronide.
    Matsunaga N; Suzuki K; Nakanishi T; Ogawa M; Imawaka H; Tamai I
    Drug Metab Pharmacokinet; 2015 Apr; 30(2):142-8. PubMed ID: 25989889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucuronidation and subsequent biliary excretion of mycophenolic acid in rat sandwich-cultured hepatocytes.
    Tetsuka K; Gerst N; Tamura K; Masters JN
    Drug Metab Pharmacokinet; 2014; 29(2):129-34. PubMed ID: 24025987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRP4 is responsible for the efflux transport of mycophenolic acid β-d glucuronide (MPAG) from hepatocytes to blood.
    Berthier J; Benmameri M; Sauvage FL; Fabre G; Chantemargue B; Arnion H; Marquet P; Trouillas P; Picard N; Saint-Marcoux F
    Xenobiotica; 2021 Jan; 51(1):105-114. PubMed ID: 32820679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal glucuronidation and multidrug resistance protein 2-/ multidrug resistance protein 4-mediated efflux of mycophenolic acid: interaction with cyclosporine and tacrolimus.
    El-Sheikh AA; Koenderink JB; Wouterse AC; van den Broek PH; Verweij VG; Masereeuw R; Russel FG
    Transl Res; 2014 Jul; 164(1):46-56. PubMed ID: 24486136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic Disposition of Gemfibrozil and Its Major Metabolite Gemfibrozil 1-O-β-Glucuronide.
    Kimoto E; Li R; Scialis RJ; Lai Y; Varma MV
    Mol Pharm; 2015 Nov; 12(11):3943-52. PubMed ID: 26378985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of intestinal absorption and enterohepatic circulation of mycophenolic Acid and its 7-O-glucuronide in rats.
    Saitoh H; Kobayashi M; Oda M; Nakasato K; Kobayashi M; Tadano K
    Drug Metab Pharmacokinet; 2006 Oct; 21(5):406-13. PubMed ID: 17072094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycophenolic acid (MPA) and its glucuronide metabolites interact with transport systems responsible for excretion of organic anions in the basolateral membrane of the human kidney.
    Wolff NA; Burckhardt BC; Burckhardt G; Oellerich M; Armstrong VW
    Nephrol Dial Transplant; 2007 Sep; 22(9):2497-503. PubMed ID: 17526543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic Basis of Cabotegravir-Glucuronide Disposition in Humans.
    Patel M; Eberl HC; Wolf A; Pierre E; Polli JW; Zamek-Gliszczynski MJ
    J Pharmacol Exp Ther; 2019 Aug; 370(2):269-277. PubMed ID: 31175220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Species differences in sinusoidal and canalicular efflux transport of mycophenolic acid 7-O-glucuronide in sandwich-cultured hepatocytes.
    Tetsuka K; Gerst N; Tamura K; Masters JN
    Pharmacol Res Perspect; 2014 Apr; 2(2):e00035. PubMed ID: 25505584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycophenolic acid glucuronide is transported by multidrug resistance-associated protein 2 and this transport is not inhibited by cyclosporine, tacrolimus or sirolimus.
    Patel CG; Ogasawara K; Akhlaghi F
    Xenobiotica; 2013 Mar; 43(3):229-35. PubMed ID: 22934787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of mycophenolic acid alone and in combination with its metabolite mycophenolic acid glucuronide on rat embryos in vitro.
    Schmidt F; Eckardt K; Shakibaei M; Glander P; Stahlmann R
    Arch Toxicol; 2013 Feb; 87(2):361-70. PubMed ID: 22914985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of poloxamer 407-induced hyperlipidemia on hepatic multidrug resistance protein 2 (Mrp2/Abcc2) and the pharmacokinetics of mycophenolic acid in rats.
    Kwon MH; Yoon JN; Baek YJ; Kim YC; Cho YY; Kang HE
    Biopharm Drug Dispos; 2016 Sep; 37(6):352-65. PubMed ID: 27241939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporin A, but not tacrolimus, inhibits the biliary excretion of mycophenolic acid glucuronide possibly mediated by multidrug resistance-associated protein 2 in rats.
    Kobayashi M; Saitoh H; Kobayashi M; Tadano K; Takahashi Y; Hirano T
    J Pharmacol Exp Ther; 2004 Jun; 309(3):1029-35. PubMed ID: 14978191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction and transport characteristics of mycophenolic acid and its glucuronide via human organic anion transporters hOAT1 and hOAT3.
    Uwai Y; Motohashi H; Tsuji Y; Ueo H; Katsura T; Inui K
    Biochem Pharmacol; 2007 Jun; 74(1):161-8. PubMed ID: 17462604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Difference between pharmacokinetics of mycophenolic acid (MPA) in rats and that in humans is caused by different affinities of MRP2 to a glucuronized form.
    Takekuma Y; Kakiuchi H; Yamazaki K; Miyauchi S; Kikukawa T; Kamo N; Ganapathy V; Sugawara M
    J Pharm Pharm Sci; 2007; 10(1):71-85. PubMed ID: 17498396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of arsenic hepatobiliary transport using sandwich-cultured human hepatocytes.
    Roggenbeck BA; Carew MW; Charrois GJ; Douglas DN; Kneteman NM; Lu X; Le XC; Leslie EM
    Toxicol Sci; 2015 Jun; 145(2):307-20. PubMed ID: 25752797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanistic Modeling of the Hepatic Disposition of Estradiol-17
    Ito K; Sjöstedt N; Brouwer KLR
    Drug Metab Dispos; 2020 Feb; 48(2):116-122. PubMed ID: 31744810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetic influences on mycophenolate therapy.
    Barraclough KA; Lee KJ; Staatz CE
    Pharmacogenomics; 2010 Mar; 11(3):369-90. PubMed ID: 20235793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPLC determination of mycophenolic acid and mycophenolic acid glucuronide in human plasma with hybrid material.
    Bolon M; Jeanpierre L; El Barkil M; Chelbi K; Sauviat M; Boulieu R
    J Pharm Biomed Anal; 2004 Nov; 36(3):649-51. PubMed ID: 15522544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.